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-1,4-Galactosyltransferase 1 (Gal-T1) transfers galac-
tose (Gal) from UDP-Gal to N-acetylglucosamine (Glc-
NAc), which constitutes its normal galactosyltrans-
ferase (Gal-T) activity. In the presence of -lactalbumin
(LA), it transfers Gal to Glc, which is its lactose synthase
(LS) activity. It also transfers glucose (Glc) from UDP-
Glc to GlcNAc, constituting the glucosyltransferase
(Glc-T) activity, albeit at an efficiency of only 0.3–0.4% of
Gal-T activity. In the present study, we show that LA
increases this activity almost 30-fold. It also enhances
the Glc-T activity toward various N-acyl substituted glu-
cosamine acceptors. Steady state kinetic studies of
Glc-T reaction show that the Km for the donor and ac-
ceptor substrates are high in the absence of LA. In the
presence of LA, the Km for the acceptor substrate is
reduced 30-fold, whereas for UDP-Glc it is reduced only
5-fold. In order to understand this property, we have
determined the crystal structures of the Gal-T1LA com-
plex with UDP-GlcMn2 and with N-butanoyl-glucosa-
mine (N-butanoyl-GlcN), a preferred sugar acceptor in
the Glc-T activity. The crystal structures reveal that
although the binding of UDP-Glc is quite similar to UDP-
Gal, there are few significant differences observed in
the hydrogen bonding interactions between UDP-Glc
and Gal-T1. Based on the present kinetic and crystal
structural studies, a possible explanation for the role of
LA in the Glc-T activity has been proposed.
Glycosyltransferases constitute a superfamily of an increas-
ing number of enzymes that are involved in the synthesis of
complex carbohydrates present on glycoproteins and glycolip-
ids. They transfer the glycosyl moiety of nucleotide derivatives
to various sugar acceptors. -1,4-Galactosyltransferase (4Gal-
T)1 (EC 2.4.1.38), is one of the subfamilies of glycosyltrans-
ferase superfamily, which comprises at least seven members,
Gal-T1 to Gal-T7 (1–9). They catalyze the transfer of galactose
(Gal) from UDP-Gal to different sugar acceptors. For example,
Gal-T1, the milk galactosyltransferase enzyme transfers Gal to
the non-reducing terminal N-acetylglucosamine (GlcNAc) res-
idue of glycans to form -1,4-linked galactosylated glycan and
to free GlcNAc to form N-acetyllactosamine (1), whereas
Gal-T6 transfers Gal to Glc in glucosylceramide synthesizing
lactosylceramide (10). Gal-T1 has been reported to be able to
use, at a lower efficiency, other N-acetyl/N-acyl substituted
sugars such as N-acetyl-D-mannosamine, N-acetylmuramic ac-
ids as sugar acceptors (11). It also does not show an absolute
requirement for UDP-Gal as a sugar donor since it can transfer
glucose (Glc), 2-deoxy-Glc, arabinose, and GalNAc from their
UDP derivatives, albeit at very low efficiencies (12–14). The
transfer of Glc occurs at a rate of only 0.3–0.5% of that of Gal,
and the product Glc1–4GlcNAc has been well characterized
(13, 14). In recent years, many other transferases have been
shown to transfer related sugars from their UDP-derivatives,
albeit with a lesser efficiency. For example, the glucosylcera-
mide synthase, which transfers Glc from UDP-Glc to ceramide
to synthesize glucosylceramide, can also transfer Gal from
UDP-Gal to ceramide to synthesize galactosylceramide with
10% efficiency (15).
The normal galactosyl acceptor specificity of some 4Gal-T
family members, in particular of Gal-T1, is altered from Glc-
NAc to Glc by -lactalbumin (LA), a mammary gland-specific
Ca2 ion-binding protein that has sequence and structural
similarity to c-type lysozyme (16). The transfer of galactose to
glucose to synthesize lactose by Gal-T1 in the presence of LA
constitutes the lactose synthase (LS) activity of Gal-T1. In the
present study we show that, in the presence of LA, Gal-T1 can
transfer Glc from UDP-Glc to GlcNAc, at an 30-fold higher
efficiency than in the absence of LA. This constitutes its glu-
cosyltransferase (Glc-T) activity, which compares to an effi-
ciency of 10% of Gal transfer from UDP-Gal to GlcNAc. In
order to better understand the broad donor specificity of
Gal-T1, we have in this report attempted to investigate the Glc
transfer activity of Gal-T1 in greater detail.
In our continued efforts to understand the structure-function
relationship between Gal-T1 and its nucleotide-sugar donor
and acceptor substrates, we have previously determined sev-
eral crystal structures of the complex of Gal-T1 with LA in the
presence of various substrates (17). These studies, together
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with the previously determined crystal structure of Gal-T1 by
Gastinel et al. (18), have led to an understanding of the enzyme
mechanism of Gal-T1 and the modulation of the acceptor spec-
ificity by LA. In order to understand the observed Glc-T activity
by Gal-T1 and the role of LA, we have determined the crystal
structure of Gal-T1 complex with UDP-Glc in the presence of
LA. Our attempts to grow the crystals of this complex in the
absence of LA have not yet been successful. We did succeed,
however, in obtaining the crystals of the complex of Gal-T1
with LA in the presence of UDP-GlcMn2 and also in the
presence of N-butanoylglucosamine (N-butanoyl-GlcN), a pre-
ferred sugar acceptor in Glc-T activity. Here we present these
crystal structures in view of the newly observed Glc-T activity.
We also found that the mutation of Cys-342 to Thr in Gal-T1
enhances the in vitro folding of the protein from the inclusion
bodies and increases the stability of Gal-T1 without perturbing
the crystal structure of the enzyme.
EXPERIMENTAL PROCEDURES
Expression, Folding, and Purification of Bovine Gal-T1—Bacterial
growth and plasmid transformations were performed using standard
procedures (19). The plasmid pEGT-d129, which encodes the catalytic
domain (residues 130–402) of bovine Gal-T1, was used for mutation
(20). Site-directed mutagenesis was performed using a CLONTECH
site-directed mutagenesis transformer kit. The transformation mixture
contained the template pEGT-d129, a selection primer (pNotApa), and
the mutagenic primer 5-GTGATCGGGAAGACCCGGATGCGCCA- 3.
Mutants were screened for the incorporated mutations by looking for
changes in restriction enzyme digestion patterns and confirmed by
DNA sequencing. The positive clones were transformed into
B834(DE3)pLysS cells. The expression and purification of the inclusion
bodies were carried out as described previously (19). The inclusion
bodies were S-sulfonated by dissolving in 5 M GdnHCl, 0.3 M sodium
sulfite, and the addition of di-sodium 2-nitro-5-thiosulfobenzoate to a
final concentration of 5 mM (21). The sulfonated protein was precipi-
tated by dilution with water, and the precipitate was washed thor-
oughly. It was re-dissolved in 5 M GdnHCl to a protein concentration of
1 mg/ml (1.9–2.0 optical density at 275 nm). The protein solution was
diluted 10-fold, in 10 portions, in a folding solution to give a final
concentration of 100 g/ml Gal-T1, 0.5 M GdnHCl, 50 mM Tris-HCl, 5
mM EDTA, 4 mM cysteamine, and 2 mM cystamine, pH 8.0 at 4°C. It was
left at 4 °C for 48 h to allow the protein to fold and then dialyzed against
3  4 liters of water containing 50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 4
mM cysteamine, and 2 mM cystamine at 4°C to remove GdnHCl. Any
protein that precipitated during dialysis was removed by centrifugation,
and the supernatant was concentrated. Typically, when 100 mg of sulfo-
nated protein was folded in a 1-liter folding solution, it yields 2–5 and
10–12 mg of active, soluble, and pure wild-type d129-Gal-T1 and C342T-
Gal-T1, respectively. The folded proteins were purified further on the
LA-agarose column (Sigma). The final, purified protein had a specific
activity that was slightly higher than that of purified milk Gal-T1.
Construction, Expression, and Folding of Mouse LA—The mouse LA
gene was PCR-amplified from the clone p35MLA that contains mouse
LA cDNA cloned into pBR322 vector.2 The oligonucleotides with a
built-in restriction site for NdeI and BamHI (shown in bold type) were
used as the 5 end and 3 end primers and were used for the PCR
amplification, respectively: 5-GGAATTCATATGACAGAGGCTTACA-
AAATGCAAGGTGACCC-3 and 5-CGCGGATCCTCAGGGCTTCTC-
ACAACGCCA-3.
The PCR-amplified products were cloned into the NdeI/BamHI re-
striction sites of the modified pET17 expression vector. The bacterial
growth, the inclusion body purification, and sulfonation methods were
quite similar to those used for Gal-T1. However, unlike Gal-T1, the
S-sulfonated LA remained soluble and was dialyzed against water
thoroughly. The concentration of the dialyzed sulfonated LA solution
was adjusted to l mg/ml by monitoring its absorption at 275 nm
(2.4–2.6 optical density). It has been shown previously that CaCl2 is
required for the folding of the recombinant LA (22). An equal volume of
a 2 folding solution containing 100 mM sodium borate buffer (pH 8.5),
5 mM calcium chloride, 8 mM reduced glutathione, and 4 mM oxidized
glutathione was added slowly to the protein solution. The resulting
solution was left at room temperature for 48 h to fold and then dialyzed
against 1 mM calcium chloride to remove the buffer and the oxido-
shuffling agents. The dialyzed protein solution was centrifuged at
15,000  g to remove any precipitate formed and then concentrated.
The active protein was isolated from the partially folded inactive pro-
tein by fractional precipitation at 40–70% ammonium sulfate concen-
tration (23). It was dissolved in water and dialyzed extensively against
1 mM calcium chloride, and the resulting protein solution was directly
used for crystallization or other studies. Using this method, 60–70% of
the starting S-sulfonated LA material was obtained in an active form.
Gal-T Enzyme Assays and Measuring the Kinetic Parameters of the
Enzyme—The in vitro assay for Gal-T1 was carried out as described
previously (20, 23). The activities of the enzymes were measured using
UDP-Gal or UDP-Glc as sugar nucleotide donors, and GlcNAc or Glc as
the acceptor sugars. The Glc-T reaction was carried out in the presence
of saturating amounts of LA. The true Km of the donor (KA) and of the
acceptor (KB), the dissociation constant of the donor, Kia, and kcat, were
obtained by two substrate analyses using the primary plots of five
concentrations of donor (UDP-Glc) and five concentrations of acceptor,
and the corresponding secondary plots of the intercepts and slopes.
Conditions were chosen such that the initial rates were linear with
respect to time and the donor and acceptor concentrations were in a
range that allowed for an accurate Michaelis-Menten plot to be derived
(Fig. 1). The data were also analyzed for a general two-substrate system
using Equations 1 and 2 (24) with the EnzFitter program, a non-linear
curve fitting program for Windows from Biosoft.
v
Vmax[A]B
KiaKB KBAKAB AB
(Eq. 1)
v
VmaxAB
KBAKAB AB
(Eq. 2)
2 P. V. Balaji and P. K. Qasba, unpublished observation.
FIG. 1. Representative double-reciprocal plots of glucosyltransferase reaction exhibited by the recombinant C342T-Gal-T1.
Steady-state velocities were determined in the absence of (A) and presence of (B) LA. The curves were fitted by the EnzFitter program, using
appropriate equations (see “Experimental Procedures”). Plots were generated by SigmaPlot.
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Equation 1 is the rate equation for sequential symmetrical initial ve-
locity pattern associated with an ordered or random equilibrium se-
quential mechanism, whereas Equation 2 is the rate equation for asym-
metric initial velocity pattern associated with a sequential mechanism
in which substrate A does not dissociate well from the ES complex. The
kinetic parameters KA, KB, Kia, and Vmax were obtained from the fitted
curves using the above rate equations. The graphical method and the
EnzFitter program gave very similar kinetic parameters.
Crystallization, Data Collection, and Refinement—The catalytic do-
main of recombinant bovine Gal-T1, residues 130–402 (d129-Gal-T1)
(mass 33 kDa), and mouse recombinant LA (mass 14 kDa) were
co-crystallized either in the presence of N-butanoyl-GlcN or UDP-glu-
cose. Crystals were grown at room temperature by hanging drop meth-
ods, using 20 mg ml1 Gal-T1 and 10 mg ml1 LA in the presence of a
substrate with the precipitant containing 100 mM NaCl, 100 mM sodium
citrate buffer (pH 5.6), and 12.5% polyethylene glycol 4000. The crystals
of the complex could only be obtained in the presence of substrates. The
concentration of substrates used during the crystallization were 10 mM
N-butanoyl-GlcN and 17 mM UDP-Glc and MnCl2. Complete three-
dimensional x-ray diffraction data were collected at beam line X9B,
National Synchrotron Light Source, Brookhaven National Laboratory,
Upton, NY, using a Quantum-4 CCD detector with a wavelength of 0.98
Å. The frames were processed using DENZO (25). The data collection
statistics are listed in Table I.
The crystal structures were solved by molecular replacement meth-
ods using AMORE (26). The crystal structure of lactose synthase (17)
without any substrate was used as a model for molecular replacement.
After initial refinement, the difference electron density maps (Fig. 2)
revealed the substrate bound to the LS molecule and were included for
further refinement. The two LS molecules in the asymmetric unit are
related by a pseudo 2-fold symmetry. During refinement, the two LS
molecules are restrained by this pseudo 2-fold symmetry. All the refine-
ments were carried out initially by XPLOR 3.85, followed by CNS1.0
(27). The coordination distances for a Mn2 ion were not restrained,
whereas those for Ca2 in LA were restrained. Only reflections with F
2 (F) were used for the refinement. The final refinement statistics are
listed in Table I. All the figures were drawn using MOLSCRIPT (28).
The Protein Data Bank access numbers for the coordinates of C342T-
Gal-T1LAGlcNAc, LSN-butanoyl-GlcN, and LSUDP-GlcMn com-
plexes are 1JN8, 1JNA, and 1JNC, respectively.
RESULTS
Mutation of Cys-342 to Thr of Gal-T1 Imparts Stability and
Increases Folding Yields—In a separate study on the role of
cysteine residues in Gal-T1, it was observed that the mutation
of Cys-342 to Thr in the catalytic domain of the wild-type
protein resulted in a 2–3-fold higher yield of the folded protein.
The mutant C342T-Gal-T1 was significantly more stable at
room temperatures and showed 18% higher activity com-
pared with the wild type (Table II). In the crystal structure of
wild-type Gal-T1, Cys-342 residue exists in the reduced form,
whereas the remaining four Cys residues form two disulfide
bonds. Recent mass spectroscopic studies have shown that,
during denaturation of milk Gal-T1, this free Cys-342 residue
is responsible for the formation of mixed disulfide bonds (29).
Therefore, the increased in vitro folding efficiency of the mu-
tant C342T-Gal-T1 may be attributed to the diminished mixed
disulfide bond formation during folding.
Specific Activities for the Three Gal-T1-catalyzed Reactions—
Gal-T1 catalyzed the transfer of Gal from UDP-Gal to GlcNAc,
generating a 1–4-linked disaccharide (Gal-T activity) (Table
II). The modifier protein, LA, changed the sugar acceptor spec-
ificity of Gal-T1 to Glc, the LS activity of the enzyme complex.
The Gal-T1, however, could also transfer Glc from UDP-Glc to
GlcNAc, exhibiting a Glc-T activity (Table II), although the
efficiency of this reaction was only 0.3% as compared with
Gal-T activity (13). We have compared these three activities of
the recombinant wild type enzyme, d129-Gal-T1, and of C342T,
in the presence and absence of LA (Table II). In the absence of
LA, Glc-T activity toward GlcNAc acceptor was only 0.3% of
that of Gal-T activity. In the presence of LA, however, this
activity increased 30-fold, equivalent to 10% of the Gal-T
activity. The mutant protein C342T-Gal-T1 also showed 10–
15% higher Glc-T activity and 40% more LS activity, com-
pared with wild type.
Glucosyltransferase Activity of C342T-Gal-T1 toward Sub-
strates Containing Different N2-acyl Derivatives of Glucosa-
mine—In the presence of LA, the transfer of Glc from UDP-Glc
to an acceptor molecule (the Glc-T activity) was enhanced by
50–75-fold, depending upon the N2-acyl substituent on the
glucosamine (GlcN) molecule (Table III, part A). The transfer to
unsubstituted Glc was approximately one-twentieth as that to
GlcNAc, indicating the importance of the N-acyl substitution at
the 2-amino group of GlcN. The acceptor binding site can ac-
commodate N-acetyl, N-propionyl, and even the bulkier N-
butanoyl group. In the absence of LA, the presence of a -ben-
zyl group at the reducing end of GlcNAc showed an activity
higher than with GlcNAc. However, LA did not increase this
activity any further as it did with GlcNAc (Table III, part A).
N,N-Diacetylchitobiose (GlcNAc1–4GlcNAc) was a less effi-
cient acceptor, and LA inhibited this weak activity even fur-
ther. In the LS reaction, the 2-hydroxyl group in Glc was
necessary for maximum enzymatic reaction since 2-deoxyglu-
cose or 2-fluoro-glucose were less efficient acceptors (Table III,
part B).
The Kinetic Parameters for the Glc-T Reaction—The steady
state kinetic analyses of C342T were carried out in the pres-
ence and absence of LA, in which acceptor and donor substrate
concentrations were varied (Fig. 1). The initial velocity data
obtained in the absence of LA with varying concentrations of
UDP-Glc at fixed concentrations of GlcNAc gave nonparallel
lines in the double-reciprocal plot, and the data fitted best to
Equation 1. Under these conditions the true Km values for
UDP-Glc and GlcNAc were much higher than the values found
for UDP-Gal and GlcNAc in the Gal-T reaction. In the presence
of LA, the data of double-reciprocal plots showed essentially
parallel lines and the data fitted best to Equation 2, where Kia,
the dissociation constant for UDP-Glc, was 0 (Table IV); the Km
values for both substrates were considerably reduced to5-fold
for UDP-Glc and 30-fold for GlcNAc, whereas the kcat increased
by 30-fold (Table IV).
Crystal Structure of C342T-Gal-T1LA Complex with Glc-
NAc—The crystal structure of the mutant C342T-Gal-T1 was
quite similar to the wild-type Gal-T1 in complex with LA and
GlcNAc. The mean r.m.s. deviation of the C atoms in the
mutant compared with the wild-type Gal-T1 structure was 0.4
Å. Although there was an additional methyl group present in
the Thr side chain compared with the Cys residue, it was well
accommodated and showed no perturbation to the local struc-
ture. The conformation and the binding of LA to C342T-Gal-T1
were quite similar to that observed with the wild type Gal-
T1LA complex with GlcNAc (17). The molecular interactions
between GlcNAc and the C342T-Gal-T1LA complex were quite
similar to those found in the Gal-T1LAGlcNAc (LSGlcNAC)
complex (17). The N-acetyl group of GlcNAc interacted with a
hydrophobic pocket on Gal-T1 formed by the residues Arg-359,
Phe-360, and Ile-363. A hydrogen bonding interaction was ob-
served between Arg-359 and the carbonyl oxygen atom of the
N-acetyl group of GlcNAc (Fig. 4A).
The Crystal Structures of the Complexes of Gal-T1 and LA
with Either N-Butanoyl-GlcN or UDP-GlcMn2—The individ-
FIG. 2. Stereo diagram showing the 2Fo  Fc electron density
for the C342T mutation. The maps were contoured at 1 level.
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ual structures of Gal-T1 and LA in both the crystal structures,
Gal-T1LA complex with N-butanoyl-GlcN and Gal-T1LA com-
plex with UDP-GlcMn2, were quite similar (Fig. 3, A and B).
The r.m.s. deviation for their C atoms was only 0.6 Å. These
structures were also similar to those of Gal-T1LAGlcNAc com-
plex and the Gal-T1LAUDPMn2 complex (17). The binding
of N-butanoyl-GlcN was quite similar to the GlcNAc binding in
the C342T-Gal-T1LAGlcNAc complex (Fig. 4, A and B). N-
Butanoyl group was very well accommodated in the N-acetyl
binding pocket formed by residues Arg-359, Phe-360, and Ile-
363 (Fig. 4B). The molecular interactions between the N-bu-
tanoyl group and Gal-T1 were also similar to those found with
N-acetyl group (Fig. 4, A and B). In addition, the extended
aliphatic chain of the N-butanoyl group is in the close vicinity
to the side chain of Met-110 of the LA molecule. Longer ali-
phatic chain in the N-acyl group would cause steric hindrance
with Met-110 residue of LA and expected to affect LA binding
to Gal-T1, which is in agreement with the previous results (30).
Comparison of UDP-GlcMn2 Binding with UDP-
GalMn2—Just as in the crystal structure of the Gal-
T1LAUDPMn2 complex (17), Mn2 ion in the crystal struc-
ture of the Gal-T1LAUDP-GlcMn2 complex has five
coordinations: two with the pyrophosphate oxygen atoms, one
with Asp-254 carboxyl oxygen atom, one with S atom of Met-
344, and one with the N1 nitrogen atom of His-347. All the
hydroxyl groups of the Glc moiety of UDP-Glc were involved in
hydrogen bonding interactions with the Gal-T1 residues, Asp-
252, Asp-318, and Glu-317 (Fig. 5, A and B). In the crystal
structure, a strong hydrogen bond with a distance of 2.7 Å was
observed between the O4 hydroxyl group of Glc of UDP-Glc and
the carboxylate oxygen atom of the Glu-317 side chain (Fig. 5,
A and B). A similar but weaker hydrogen bond (3.3 Å) was
observed for the Gal of UDP-Gal in the crystal structure of
TABLE IV
Kinetic parameters for glucose transfer to GlcNAc by C342T-Gal-T1 in
the presence and absence of LA
Substrate Parameter LA LA
UDP-Glc
kcat (s
1) 0.058 (5) 0.247 (5)
KA (M) 148 (4) 31 (2)
Kia (M) 19.5 (6) 0
GlcNAc
KB (mM) 73.8 (3) 2.5 (1)
TABLE I
Crystal structure refinement statistics
The crystals belong to a monoclinic system, with space group P21. 4Gal-T1LA is a 1:1 complex between bovine 4Gal-T1, residues 130–402,
and mouse LA.
Crystals grown in the presence of
(C342T-4Gal-T1)LAGlcNAc 4Gal-T1LAN-butanoyl-GlcN 4Gal-T1LAUDPGlcMn2
Unit cell
parameters
a (Å) 57.1 57.2 55.1
b (Å) 95.7 97.1 98.9
c (Å) 100.3 99.7 102.0
 (°) 101.4 101.1 103.9
Resolution (Å) 2.0 2.3 2.3
Reflections collected 265,383 84,832 72,447
Unique reflections 71,569 38,898 (84%) 39,806 (85%)
Rsym 0.079 0.062 0.117
Reflections used 69,391 38,816 37,326
Final R factor/Rfree 0.25/0.30 0.26/0.32 0.25/0.30
r.m.s. deviations on
Bonds (Å) 0.008 0.007 0.006
Angles (°) 1.5 1.4 1.5
TABLE II
Relative specific activities of the wild type catalytic domain of Gal-T1 (d129-Gal-T1, residues 130–402) and C342T-Gal-T1, in the
Gal-T, LS, and Glc-T reactions and comparison of the influence of -LA on these reactions
All reactions were performed under saturating conditions of all substrates and at 7 M -lactalbumin concentration (see text for assay
conditions). 100% activity is defined as 51 pmol min1 ng1 of Gal transfer to GlcNAc in the Gal-T reaction. The LS and Glc-T activities are
expressed as a percentage of Gal-T activity, which is set as 100%.
Enzyme
 -Lactalbumin  -Lactalbumin
UDP-galactose 3 GlcNAc
(Gal-T activity)
UDP-glucose 3 GlcNAc
(Glc-T activity)
UDP-galactose 3 Glc
(LS activity)
UDP-glucose 3 GlcNAc
(Glc-T activity)
% % % %
Bovine milk Gal-T1 100 0.3 110 10
d129-Gal-T1 100 0.3 129 7.8
C342T-Gal-T1 118 0.3 180 11.8
TABLE III
Catalytic activity of C342T mutant using various acceptors in
glucosyltransferase (part A) and lactose synthase (part B) reactions
A. Glucosyltransferase activity
(Gal-T1  UDP-Glc)
Activity Increase
(LA/LA)LA LA
 103 pmol/min/ng -fold
GlcNAc 28 1486 53
N-Propionyl-GlcN 20 1466 73
N-Butanoyl-GlcN 18 1031 57
Glc 0 63
-Benzyl-GlcNAc 168 162a
-GlcNAc-1,4-GlcNAc 17b 9c
B. Acceptor specificities
of lactose synthase (Gal-T1
 UDP-Gal  LA) Activity
Acceptor
pmol/min/ng
Glc 19.17
2-Deoxy-Glc 0.47
2-Fluro-Glc 0.11
Glucosamine (GlcN) 0.0
Glucosamine 2-sulfate 0.0
a Activity was measured at 15 mM acceptor concentration.
b Activity was measured at 5 mM acceptor concentration.
c Activity was measured at 3 mM acceptor concentration.
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Gal-T1UDP-GalMn2 (solved at 2.8-Å resolution).3 The O4
hydroxyl group was equatorial in Glc, whereas it was axial in
Gal. Due to this difference, the O4 hydroxyl oxygen of the Gal
in the Gal-T1UDP-GalMn2 complex was pointed toward the
acceptor binding site and formed a weak hydrogen bond with
the Asp-318 side chain carboxylate oxygen atom. In the present
crystal structure, although the O4 hydroxyl group of Glc was
hydrogen-bonded to Glu-317, it pointed away from the acceptor
binding site and Asp-318 (distance, 3.8 Å).
There were two Gal-T1LA complexes present in the asym-
metric unit, in which each complex had one bound UDP-Glc
molecule and one Mn2 ion. Although the interactions of the
donor substrate UDP-GlcMn2 with Gal-T1 were quite similar
in both complexes in the asymmetric unit, the hydrogen bond-
ing interactions observed for the O6 hydroxyl group of Glc with
Gal-T1 were quite different in these two molecules (Fig. 5, A
and B). In one molecule, the O6 hydroxyl group interacted with
Asp-318, whereas, in the other, it interacted with the Gly-315
and Glu-317 in a manner similar to those observed for UDP-
Gal binding in the Gal-T1UDP-GalMn2 complex.2 The differ-
ences in the O6 hydroxyl orientation could have been a result of
the orientation of O4 hydroxyl group in the Glc moiety. When
UDP-Glc was bound, the O4 hydroxyl group (equatorial orien-
tation) was pointing away from Asp-318, resulting in a space
between the C4 atom of Glc and the Asp-318 side chain, which
was filled by the O6 hydroxyl group (Fig. 5A). If the O4 hy-
droxyl group were in axial orientation as in Gal, it would be
pointing toward the Asp-318 side chain, leaving not enough
space between O4 atom of Gal and Asp-318. The O6 hydroxyl
group must orient away from Asp-318, similar to what is ob-
served in Fig. 5B. The hydrogen bonding interactions between
O6 and Gal-T1 seem to be important for the binding of nucle-
otide-sugar since UDP-Glc, but not UDP-xylose, is a competi-
tive inhibitor of Gal-T1 reaction (31, 32).3 B. Ramakrishnan and P. K. Qasba, unpublished observation.
FIG. 3. A, molecular diagram of Gal-T1LAUDP-GlcMn2 complex.
The molecular interactions between Gal-T1 and LA molecules are quite
similar to those observed in the Gal-T1LAN-butanoyl-GlcN complex.
However, in the protein complex, LA molecule does not interact with
the donor UDP-Glc molecule. The Ca2 and Mn2 ions are shown as
yellow and blue spheres, respectively. B, superposition of the C atoms
of the LS molecules from the crystal structure of the complex Gal-
T1LAUDP-GlcMn2 (blue) and Gal-T1LAN-butanoyl-GlcN (red). The
r.m.s. deviation between these structures is only 0.8 Å, indicating that
these two protein structures are quite similar. Although there are few
residues in the loop region, residues 60–65 on LA molecules that
exhibit differences are not involved in any interactions either with the
Gal-T1 or with substrate molecules.
FIG. 4. Stereo diagram showing the binding of GlcNAc (A) and
N-butanoyl-GlcN (B) to Gal-T1LA complex. The LA and Gal-T
secondary structures are shown in red and blue, respectively. The O1
hydroxyl group of the acceptor is hydrogen-bonded with the His32
residue of the LA molecule (dotted line). In these, interactions of both
the acceptor substrates with the Gal-T1 and LA molecules are quite
similar. A, the N-acetyl moiety of GlcNAc binds to a hydrophobic pocket
on Gal-T1 formed by the residues Arg-359, Phe-360, and Ile-363. The
carbonyl oxygen atom of the N-acetyl group forms a hydrogen bond with
the Arg-359 side chain, and the methyl group is surrounded by the
hydrophobic residues Phe-360 and Ile-363. B, like the N-acetyl group,
the N-butanoyl group also binds to the same hydrophobic pocket of
Gal-T1. In addition, the extended aliphatic chain of the N-butanoyl
group interacts with the side chain of Met-110 of LA.
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DISCUSSION
The present crystallographic study shows that the interac-
tions of UDP-Glc and Gal-T1 exhibit few significant differences
from those of UDP-Gal and Gal-T1. In the presence of LA, these
differences are reflected in the Km values for the substrates as
well in the catalytic efficiencies between Gal-T reaction and
Glc-T reaction (Tables II and IV). The property of Gal-T1 uti-
lizing alternate nucleotide-sugar donor is also shared by other
glycosyltransferases, albeit with lesser efficiency. For example,
glucosylceramide synthase, which transfers Glc from UDP-Glc
to ceramide, still exhibits 10% activity when UDP-Gal is used
as the sugar donor (15). However, the difference between glu-
cosylceramide synthase and Gal-T1 is that Gal-T1 exhibits
10% glucosyltransferase (Glc-T) activity only in the presence
of LA; in contrast, glucosylceramide synthase exhibits 10%
activity with the alternate donor substrate UDP-Gal, even in
the absence of any enhancer protein. It is possible that this may
be an intrinsic property of the galactosyltransferases to exhibit
glucosyltransferase activity or vice versa, albeit with lesser
efficiency.
In order to understand the Km values for the substrates in
the Glc-T reaction in the absence of LA, the crystal structure of
Gal-T1UDP-Glc complex in the absence of LA is essential.
Since we could not obtain such crystals, it remains to be seen
why the substrates have high Km values. LA does not interact
with either UDP-Glc or UDP-Gal in any of the crystal struc-
tures of Gal-T1LA complex with various substrates deter-
mined so far. Thus, it appears that the role of LA in stimulating
the Glc-T activity of Gal-T1 would only be at the enzyme kinetic
level and not at the level of molecular interactions between
UDP-Glc and Gal-T1. It has been suggested previously (31)
that, during Gal-T reaction, Gal-T1Mn2 complex is formed
first, to which UDP-Gal and sugar acceptor bind sequentially.
In the presence of LA during LS reaction, LA and Glc molecules
bind synergistically (33). After catalysis the product disaccha-
ride and LA dissociate, followed by UDP and Mn2. The Glc-T
reaction is also expected to follow the same ordered sequential
kinetic mechanism, and LA participates in the reaction in a
way similar to LS reaction as described below.
Previously, we provided a structural basis for the Gal-T and
LS kinetic mechanism based on the crystal structures of Gal-T1
(17). Briefly, Gal-T1 exists in two different conformations, I and
II, which differ in the conformation between residues 345 and
365 and in the side chain orientation of Trp-314 (17, 18). In
conformation I, these residues do not interact with UDP-Gal as
they are away from the UDP-Gal binding site. In conformation
II, on the other hand, they are placed in such a way that many
of these residues not only bind to UDP-Gal but also bury it. In
the crystal structure of substrate free Gal-T1 (18), Gal-T1 is
found in conformation I, whereas it is found in conformation II
in its complex with UDP-GalMn2,2 or as in the UDP-
GlcMn2LA complex (Fig. 3A). It has been proposed that
Gal-T1 exists in conformation I to which a free UDP-Gal mol-
ecule can bind (17). Upon binding, a conformational change
takes place, involving residues 345–365 and Trp-314, which
gives rise to conformation II of Gal-T1. This conformational
change is important for the catalytic reaction to proceed for-
ward, since it creates not only the sugar acceptor binding
pocket but also the LA binding site so that the sugar acceptor
GlcNAc can bind to the Gal-T1UDP-GalMn2 complex in con-
formation II. After catalysis, the product disaccharide leaves
first followed by the reversal of conformation II to I, which
releases the UDP molecule. The UDP-Gal-dependent confor-
mational change is supported by earlier spectroscopic and pho-
toinactivation studies; these studies had suggested that, upon
UDP-Gal binding, Gal-T1 undergoes a conformational change
protecting one Trp residue from photo-inactivation (30, 34). It
was inferred that the sugar moiety of UDP-sugar is important
for this conformational change, as UDP alone did not induce
the conformational change to the same extent as UDP-Gal (30).
The inability of UDP to stabilize the conformation II is crucial
for its dissociation from the binding site.
On the basis of the Glc-T kinetic data obtained in the present
study and taking into consideration the results of the earlier
spectroscopic studies (30) and the structural data (17, 18), we
propose the following role for LA in its Glc-T reaction. In the
absence of LA, the kinetic data suggest that UDP-Glc dissoci-
ates from the enzymeUDP-Glc complex (Kia 	 20 M), whereas
in Gal-T reaction, UDP-Gal does not dissociate from the
enzymeUDP-Gal complex (31). The free UDP-Glc molecule can
bind to Gal-T1 only when Gal-T1 is in conformation I, and, once
Gal-T1 changes its conformation to II, the bound UDP-Glc gets
buried in this conformation and cannot dissociate from enzyme
(conformation II)UDP-Glc complex. For UDP-Glc to dissociate
from the enzymeUDP-Glc complex, Gal-T1 must exist in con-
formation I. Therefore, it appears that, similar to UDP, UDP-
Glc also does not induce the conformational change from I to II
FIG. 5. Binding of UDP-Glc and Mn2 ion to the Gal-T1LA
complex. There are two Gal-T1LA complexes in the asymmetric unit
(A and B), each with one bound UDP-GlcMn2. The Mn2 ion coordi-
nation is the same in both the molecules. Although the molecular
interactions between UDP-Glc and Gal-T1 are mostly the same in both
the molecules of the asymmetric unit, the interactions of the O6 hy-
droxyl group with Gal-T1 are different in the two molecules. In one, the
O6 hydroxyl group is hydrogen-bonded to the side chain carboxylate
group of Asp-318 (A), whereas, in the other, it is hydrogen-bonded to the
side chain carboxylate group of Glu-317 and the backbone nitrogen
atom of Gly-315 residue (B). All the H-bonds and the Mn2 coordination
bonds are shown by dotted lines.
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as efficiently as UDP-Gal, thus hindering the catalytic reaction
from proceeding.
In the presence of LA, according to the kinetic data, UDP-Glc
does not dissociate from the enzymeUDP-Glc complex (Kia 	
0); therefore, the presence of LA seems to stabilize the
enzymeUDP-Glc complex in conformation II (Table IV). LA
binds to Gal-T1 only if Gal-T1 is in conformation II (17), and,
for steric reasons, upon its binding, Gal-T1 cannot reverse its
conformation from II to I (17). Therefore, by selectively binding
to enzymeUDP-Glc complex in conformation II, LA might shift
the equilibrium toward conformation II of enzymeUDP-Glc
complex. Further, it is possible that LA may not dissociate
unless the product N-acetylcellobiosamine is formed, thereby
enhancing the catalytic reaction to proceed forward. By stabi-
lizing the conformation II and through direct interactions with
the acceptor substrate, LA may enhance the binding of the
acceptor GlcNAc in the Glc-T reaction. In all the three catalytic
reactions (Gal-T, Glc-T, and LS), the conformational change
from I to II is important not only for the LA and acceptor
binding but also for the donor binding. In conformation II only,
the sugar acceptor and LA binding sites are exposed for the
binding and the His-347 residue can participate in Mn2 ion
coordination (17). Clearly, the ability to introduce conforma-
tional change in Gal-T1 by the UDP-sugar seems to be impor-
tant for the enzyme catalysis even though the specific role of
the sugar moiety in UDP-sugars in this process remains to be
determined.
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